Company intelligence / Profile preview

Sarborg

Cambridge, United Kingdom

Ownership: Private
Development stage: Other

Overview

Sarborg provides an AI-driven, cybernetics-based technology platform focused on drug repurposing and pharmaceutical data analytics, offering proprietary dashboards and disease–drug signature mapping for pharma R&D and clinical trial optimization; its technology has been validated via revenue-generating contracts with public biopharma clients[1][2][3][4][5][8].

Industry: Drug Discovery Services

Partnerships

Conduit Pharmaceuticals

Beyond the preview

Go deeper on Sarborg.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sarborg.

Explore the full profile